Extended ECG Monitoring in Patients with Hypertrophic Cardiomyopathy: The Tempo-HCM Study.

ABSTRACT: Background/Objectives: Current guidelines recommend 24-48 h Holter for risk stratification and atrial fibrillation (AF) screening in hypertrophic cardiomyopathy (HCM). However, the limited duration of this approach may not provide optimal sensitivity. In addition, extended ECG monitoring has been demonstrated to be more effective in detecting arrhythmias in other clinical entities. We aimed to assess the utility of extended ECG monitoring for 30 days in a non-high-risk cohort of HCM patients. Methods: We conducted a prospective multicentre study with 113 non-high-risk HCM patients who underwent 30-day ECG monitoring with a dedicated device. We compared the detection of relevant arrhythmias (AF, atrial flutter, and non-sustained ventricular tachycardia) during 30-day monitorin

SUBMITTER: Caro-Codon J 

PROVIDER: S-EPMC12565036 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature